Home Forums Other Specialities Cardiothoracic Medicine & Surgery Thrombectomy-Coronary vessel occlusion

This topic contains 1 voice and has 0 replies.
1 voice
0 replies
  • Author
    Posts
  • #1276
    Anonymous
    Inactive

    Multicenter Study Circ Cardiovasc Interv
    . 2023 Feb;16(2):e012433. doi: 10.1161/CIRCINTERVENTIONS.122.012433. Epub 2023 Feb 21.
    Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study
    S Jay Mathews 1, Sahil A Parikh 2, Willis Wu 3, D Christopher Metzger 4, Jeffrey W Chambers 5, Magdi G H Ghali 6, Michael James Sumners 7, Brian C Kolski 8, Duane S Pinto 9, Suhail Dohad 10
    Affiliations expand
    PMID: 36802804 PMCID: PMC9944712 DOI: 10.1161/CIRCINTERVENTIONS.122.012433
    Abstract
    Background: Poor myocardial reperfusion due to distal embolization and microvascular obstruction after percutaneous coronary intervention is associated with increased risk of morbidity and mortality. Prior trials have not shown a clear benefit of routine manual aspiration thrombectomy. Sustained mechanical aspiration may mitigate this risk and improve outcomes. The objective of this study is to evaluate sustained mechanical aspiration thrombectomy before percutaneous coronary intervention in high thrombus burden acute coronary syndrome patients.

    Methods: This prospective study evaluated the Indigo CAT RX Aspiration System (Penumbra Inc, Alameda CA) for sustained mechanical aspiration thrombectomy before percutaneous coronary intervention at 25 hospitals across the USA. Adults presenting within 12 hours of symptom onset with high thrombus burden and target lesion(s) located in a native coronary artery were eligible. The primary end point was a composite of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or new or worsening New York Heart Association class IV heart failure within 30 days. Secondary end points included Thrombolysis in Myocardial Infarction thrombus grade, Thrombolysis in Myocardial Infarction flow, myocardial blush grade, stroke, and device-related serious adverse events.

    Results: From August 2019 through December 2020, a total of 400 patients were enrolled (mean age 60.4 years, 76.25% male). The primary composite end point rate was 3.60% (14/389 [95% CI, 2.0-6.0%]). Rate of stroke within 30 days was 0.77%. Final rates of Thrombolysis in Myocardial Infarction thrombus grade 0, Thrombolysis in Myocardial Infarction flow 3, and myocardial blush grade 3 were 99.50%, 97.50%, and 99.75%, respectively. No device-related serious adverse events occurred.

    Conclusions: Sustained mechanical aspiration before percutaneous coronary intervention in high thrombus burden acute coronary syndrome patients was safe and was associated with high rates of thrombus removal, flow restoration, and normal myocardial perfusion on final angiography.

    Keywords: acute coronary syndrome; myocardial infarction; percutaneous coronary intervention.

You must be logged in to reply to this topic.